Press Releases RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.428 ^USD	+2.82%		-5.31%	-70.68%

Apr. 24	RedHill Biopharma Ltd Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study	CI
Apr. 08	RedHill Biopharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RedHill Biopharma : Announces First Patient Enrolled in U.S. Government- Supported COVID-19 Study - Form 6-K	Apr. 24	PU
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights	Apr. 09	AQ
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price	Apr. 03	AQ
RedHill Biopharma : Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs - Form 6-K	Mar. 05	PU
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs	Mar. 05	PR
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis, New Publication	Feb. 21	AQ
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication	Feb. 20	PR
Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL	Jan. 31	AQ
RedHill Biopharma Announces $8 Million Registered Direct Offering	Jan. 26	AQ
RedHill Announces New USPTO Patent Grant for Talicia for H. pylori Treatment Through 2042	Jan. 26	AQ
RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K	Dec. 20	PU
RedHill Biopharma : Exercise of Existing Warrants Resulting in $4 Million Proceeds to the Company - Form 6-K	Dec. 06	PU
RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study	Dec. 04	PR
Small Cap Companies Spearheading Innovation in the Biopharma Healthcare Sector" INBS, RDHL, CDIO, VTAK, DNA	Nov. 30	AQ
RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034	Nov. 27	PR
RedHill Biopharma Announces the Transfer of its Listing to the Nasdaq Capital Market	Nov. 15	AQ
The Street Reports: Guide to Penny Stocks Look Now! CLNV, ARAV, RDHL, ATHX, EPAZ	23-10-19	AQ
RedHill Biopharma : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	23-10-16	PU
RedHill Biopharma : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	23-10-10	PU
RedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo Study	23-10-03	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Press Releases

Filters